Dr. Ryutaro Hirose, MD

Dr. Hirose practices at UCSF Student Health and Counseling Services in San Francisco, California.

Dr. Hirose's NPI, 1952365272, was assigned on April 13, 2006. Dr. Hirose holds Washington license MD61468223.

Dr. Hirose's primary practice is UCSF Student Health and Counseling Services, at 500 Parnassus Ave, San Francisco, CA 94143. The practice phone is (415) 476-1281.

Dr. Hirose's primary practice is UCSF Student Health and Counseling Services in San Francisco, California. Dr. Hirose is also affiliated with UW Medical Center - Montlake. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Hirose to 1 more hospital and 5 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hirose practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Hirose's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Hirose is licensed in Washington.

CMS data shows 60 Medicare services from Dr. Hirose across 4 procedure codes in 2023, for 20 Medicare patients. Medicare paid $41,701 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 20 Medicare patients who saw Dr. Hirose in 2024. 75% of them have high blood pressure, and 70% have chronic kidney disease. Their average risk score is 5.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hirose's median patient age at 48, with 44% women.

In 2024, Dr. Hirose wrote 51 Medicare Part D claims. 84% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $80 in total drug cost. In 2022, CMS named 90 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Hirose for performance year 2024, reported as part of a group. Dr. Hirose accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 91 papers to Dr. Hirose, published from 2010 to 2025. 2020 was the busiest year, with 9. The most frequent topics are Tissue and Organ Procurement, Waiting Lists and Liver Transplantation. Dr. Hirose has published most often in Am J Transplant. Dr. Hirose's most frequent co-authors are Neil Mehta, Ajay K. Israni, MD and Peter G. Stock, MD.

Dmand AI links Dr. Hirose to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Carcinoma, Hepatocellular, Kidney Failure, Chronic and Liver Neoplasms.

CMS Open Payments shows 23 general payments to Dr. Hirose from 3 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 75% of the total. Intuitive Surgical, Inc. paid the most, $2,881.